Skip to main content
Article thumbnail
Location of Repository

Expression of calcium-binding protein S100A2 in breast lesions

By D Liu, P S Rudland, D R Sibson, A Platt-Higgins and R Barraclough

Abstract

A suppression subtraction cDNA library representing mRNAs expressed at a higher level in a benign breast tumour-derived cell line relative to the malignant MCF-7A cell line contained cDNAs corresponding to mRNAs for plasminogen activator inhibitor I, annexin VIII and the EF-hand protein S100A2. S100A2 protein has previously been shown to be expressed in normal human breast epithelium, but not in human breast carcinoma cell lines. Using a PCR-based assay and in situ hybridization on histological sections of human breast specimens, the mRNA for S100A2 was shown to be present in all benign breast lesions examined as well as in normal epithelium. S100A2 mRNA was detectable in 37% of specimens of carcinoma in situ, but in less than 15% of carcinoma specimens. The results suggest that the loss of S100A2 is associated with the development of malignant cells and is not associated with early tumour development. © 2000 Cancer Research Campaign http://www.bjcancer.co

Topics: Regular Article
Publisher: Nature Publishing Group
OAI identifier: oai:pubmedcentral.nih.gov:2363420
Provided by: PubMed Central

Suggested articles

Citations

  1. (1990). Basic local alignment search tool.
  2. (1997). Repression of the candidate tumor suppressor gene S100A2 in breast cancer is mediated by site specific hypermethylation.
  3. (1995). The TNFR2-TRAF signaling complex contains two novel proteins related to baculoviral inhibitor of apoptosis proteins.

To submit an update or takedown request for this paper, please submit an Update/Correction/Removal Request.